Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    TransMedics Group Inc.

    NASDAQ: TMDX · Real-Time Price · USD
    140.78
    1.38 (0.99%)
    At close: Jun 10, 2025, 3:59 PM
    141.00
    0.16%
    After-hours: Jun 10, 2025, 06:38 PM EDT

    TransMedics Statistics

    Share Statistics

    TransMedics has 33.83M shares outstanding. The number of shares has increased by 2.2% in one year.

    Shares Outstanding

    n/a
    		 33.83M

    Shares Change (YoY)

    n/a
    		 2.2%

    Shares Change (QoQ)

    n/a
    		 0.3%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 32.59M

    Failed to Deliver (FTD) Shares

    n/a
    		 924

    FTD / Avg. Volume

    n/a
    		 0.09%

    Short Selling Information

    The latest short interest is 8.1M, so 23.95% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 8.1M

    Short % of Shares Out

    n/a
    		 23.95%

    Short % of Float

    n/a
    		 41.38%

    Short Ratio (days to cover)

    n/a
    		 5.28

    Valuation Ratios

    The PE ratio is 58.42 and the forward PE ratio is 55.81. TransMedics's PEG ratio is -0.24.

    PE Ratio

    n/a
    		 58.42

    Forward PE

    n/a
    		 55.81

    PS Ratio

    n/a
    		 4.69

    Forward PS

    n/a
    		 4.2

    PB Ratio

    n/a
    		 9.06

    P/FCF Ratio

    n/a
    		 -25.6

    PEG Ratio

    n/a
    		 -0.24
    Financial Ratio History

    Enterprise Valuation

    TransMedics has an Enterprise Value (EV) of 2.25B.

    EV / Sales

    n/a
    		 5.1

    EV / EBITDA

    n/a
    		 32.22

    EV / EBIT

    n/a
    		 46.18

    EV / FCF

    n/a
    		 -27.84

    Financial Position

    The company has a current ratio of 8.3, with a Debt / Equity ratio of 2.27.

    Current Ratio

    n/a
    		 8.3

    Quick Ratio

    n/a
    		 7.52

    Debt / Equity

    n/a
    		 2.27

    Debt / EBITDA

    n/a
    		 7.41

    Debt / FCF

    n/a
    		 -6.4

    Interest Coverage

    n/a
    		 2.6

    Financial Efficiency

    Return on Equity is 15.51% and Return on Invested Capital is 4.98%.

    Return on Equity

    n/a
    		 15.51%

    Return on Assets

    n/a
    		 4.41%

    Return on Invested Capital

    n/a
    		 4.98%

    Revenue Per Employee

    n/a
    		 $606,510.99

    Profits Per Employee

    n/a
    		 $48,714.29

    Employee Count

    n/a
    		 728

    Asset Turnover

    n/a
    		 0.55

    Inventory Turnover

    n/a
    		 3.85

    Taxes

    Income Tax

    n/a
    		 316K

    Effective Tax Rate

    n/a
    		 0.88%

    Stock Price Statistics

    The stock price has increased by -3.62% in the last 52 weeks. The beta is 2.08, so TransMedics's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.08

    52-Week Price Change

    n/a
    		 -3.62%

    50-Day Moving Average

    n/a
    		 101.28

    200-Day Moving Average

    n/a
    		 97.08

    Relative Strength Index (RSI)

    n/a
    		 80.39

    Average Volume (20 Days)

    n/a
    		 1,053,255

    Income Statement

    In the last 12 months, TransMedics had revenue of 441.54M and earned 35.46M in profits. Earnings per share was 1.07.

    Revenue

    n/a
    		 441.54M

    Gross Profit

    n/a
    		 262.08M

    Operating Income

    n/a
    		 37.5M

    Net Income

    n/a
    		 35.46M

    EBITDA

    n/a
    		 69.95M

    EBIT

    n/a
    		 50.19M

    Earnings Per Share (EPS)

    n/a
    		 1.07
    Full Income Statement

    Balance Sheet

    The company has 336.65M in cash and 518.29M in debt, giving a net cash position of -181.64M.

    Cash & Cash Equivalents

    n/a
    		 336.65M

    Total Debt

    n/a
    		 518.29M

    Net Cash

    n/a
    		 -181.64M

    Retained Earnings

    n/a
    		 -468.24M

    Total Assets

    n/a
    		 837.53M

    Working Capital

    n/a
    		 450.31M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 48.8M and capital expenditures -129.74M, giving a free cash flow of -80.94M.

    Operating Cash Flow

    n/a
    		 48.8M

    Capital Expenditures

    n/a
    		 -129.74M

    Free Cash Flow

    n/a
    		 -80.94M

    FCF Per Share

    n/a
    		 -2.44
    Full Cash Flow Statement

    Margins

    Gross margin is 59.36%, with operating and profit margins of 8.49% and 8.03%.

    Gross Margin

    n/a
    		 59.36%

    Operating Margin

    n/a
    		 8.49%

    Pretax Margin

    n/a
    		 8.1%

    Profit Margin

    n/a
    		 8.03%

    EBITDA Margin

    n/a
    		 15.84%

    EBIT Margin

    n/a
    		 8.49%

    FCF Margin

    n/a
    		 -18.33%

    Dividends & Yields

    TMDX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 1.71%

    FCF Yield

    n/a
    		 -3.91%
    Dividend Details

    Analyst Forecast

    The average price target for TMDX is $120, which is -13.9% lower than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $120

    Price Target Difference

    n/a
    		 -13.9%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 13
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 12.85

    Graham Upside

    n/a
    		 -90.78%

    Scores

    Altman Z-Score

    n/a
    		 5.25

    Piotroski F-Score

    n/a
    		 5

    Add to Watchlist